Teva Faces Massive Investor Suit Over Opioid Scandal Fallout

By Katryna Perera · September 15, 2023, 9:16 PM EDT

Teva Pharmaceutical Industries Ltd. has been hit with a suit in Connecticut federal court from several Israeli institutional investors alleging the company's role in facilitating the United States' opioid epidemic damaged shareholders once...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Psagot Mutual Funds, Ltd. et al v. Teva Pharmaceutical Industries Ltd. et al

Case Number

Court

Connecticut

Nature of Suit

Securities/Commodities

Date Filed

September 14, 2023

Recent Articles By Katryna

January 10, 2025
9th Circ. Affirms Hearing Aid Co.'s Win Over Investor Suit
January 09, 2025
CFPB Hit With 2nd Suit Over Medical Debt Reporting Rule
December 05, 2024
FINRA Fines Firm $900K Over SPAC Underwriting Fee Issues
November 04, 2024
Late New Evidence Can't Revive Investor Suit, Judge Says
October 31, 2024
Masimo Sues Ex-CEO Over 'Unprecedented' $450M Demand
October 28, 2024
SEC Sues To Enforce Subpoena On Telehealth Co.
September 27, 2024
Pharma Co. Amarin Beats Class Action Over Patent Issues
September 26, 2024
Healthcare REIT Defeats Investor Suit For Good
September 23, 2024
Mallinckrodt Brass Can't Avoid Investor Suit Over 2nd Ch. 11
September 23, 2024
SEC Scores $12M Judgment In Unregistered Dealer Case